CVB Financial, ClickSoftware Technologies and BioDelivery Sciences International lead small-cap in pre-market
CVB Financial Corp. (Nasdaq:CVBF), ClickSoftware Technologies Ltd. (Nasdaq:CKSW) and BioDelivery Sciences International Inc. (Nasdaq:BDSI) are among most actively traded small-cap companies in Wednesday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: Fuqi International Inc. (Nasdaq:FUQI), Spectrum Pharmaceuticals Inc. (Nasdaq:SPPI), Biocryst Pharmaceuticals Inc. (Nasdaq:BCRX), Spartan Motors Inc. (Nasdaq:SPAR), Geron Corp. (Nasdaq:GERN) and A Power Energy Generation Systems Ltd. (Nasdaq:APWR).
Orexigen Therapeutics, Spectrum Pharmaceuticals and PetMed Express lead small-cap volume in pre-market
Orexigen Therapeutics Inc. (Nasdaq:OREX), Spectrum Pharmaceuticals Inc. (Nasdaq:SPPI) and PetMed Express Inc. (Nasdaq:PETS) are among the most actively traded companies in Monday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: Infinera Corp. (Nasdaq:INFN), CardioNet Inc. (Nasdaq:BEAT), ClickSoftware Technologies Ltd. (Nasdaq:CKSW), China Housing & Land Development Inc. (Nasdaq:CHLN), Fuqi International Inc. (Nasdaq:FUQI) and BioDelivery Sciences International Inc. (Nasdaq:BDSI).
MSC Software, XenoPort and Cheesecake Factory lead small-cap volume in pre-market
MSC Software Corp. (Nasdaq:MSCS), XenoPort Inc. (Nasdaq:XNPT) and Cheesecake Factory Inc. (Nasdaq:CAKE) are among the most actively traded companies in Wednesday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: CSG Systems International Inc. (Nasdaq:CSGS), Spectrum Pharmaceuticals Inc. (Nasdaq:SPPI), Websense Inc. (Nasdaq:WBSN), Century Aluminum Co. (Nasdaq:CENX), BioDelivery Sciences International Inc. (Nasdaq:BDSI) and Energy Conversion Devices Inc. (Nasdaq:ENER).
A Power Energy Generation Systems, Force Protection and BioDelivery Sciences International lead small-cap volume in pre-market
A Power Energy Generation Systems Ltd. (Nasdaq:APWR), Force Protection Inc. (Nasdaq:FRPT) and BioDelivery Sciences International Inc. (Nasdaq:BDSI) are among the most actively traded companies in Tuesday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: JA Solar Holdings Co Ltd. (Nasdaq:JASO), Spectrum Pharmaceuticals In.c (Nasdaq:SPPI), AgFeed Industries Inc. (Nasdaq:FEED), Eagle Bulk Shipping Inc. (Nasdaq:EGLE), Solarfun Power Holdings Co Ltd. (Nasdaq:SOLF) and Century Aluminum Co. (Nasdaq:CENX).
AgFeed Industries, Paragon Shipping and MannKind lead small-cap volume in pre-market
AgFeed Industries Inc. (Nasdaq:FEED), Paragon Shipping Inc. (Nasdaq:PRGN) and MannKind Corp. (Nasdaq:MNKD) are among the most actively traded companies in Monday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: BioDelivery Sciences International Inc. (Nasdaq:BDSI), Canadian Solar Inc. (Nasdaq:CSIQ), UAL Corp. (Nasdaq:UAUA), Geron Corp. (Nasdaq:GERN), Exide Technologies (Nasdaq:XIDE) and Vivus Inc. (Nasdaq:VVUS).
Limelight Networks, Fuqi International and BioDelivery Sciences International among 52-week highs
Limelight Networks Inc. (Nasdaq:LLNW), Fuqi International Inc. (Nasdaq:FUQI) and BioDelivery Sciences International Inc. (Nasdaq:BDSI) are among the new 52-week highs in Tuesday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: SIGA Technologies Inc. (Nasdaq:SIGA), Gander Mountain Co. (Nasdaq:GMTN), Virtus Investment Partners Inc. (Nasdaq:VRTS), Smith Micro Software Inc. (Nasdaq:SMSI), ShoreTel Inc. (Nasdaq:SHOR) and Kirklands Inc. (Nasdaq:KIRK).
VNUS Medical Technologies, Virtus Investment Partners and Gander Mountain among 52-week highs
VNUS Medical Technologies Inc. (Nasdaq:VNUS), Virtus Investment Partners Inc. (Nasdaq:VRTS) and Gander Mountain Co. (Nasdaq:GMTN) are among the new 52-week highs in Friday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: BioDelivery Sciences International Inc. (Nasdaq:BDSI), Cubic Corp. (Nasdaq:CUB), Seneca Foods Corp. (Nasdaq:SENEA), Orion Marine Group Inc. (Nasdaq:OMGI), Walter Investment Management Corp. (Nasdaq:WAC) and Ocwen Financial Corp. (Nasdaq:OCN).
Pre-market: CyberOptics meets 3Q expectations
Shares of optical process control sensors supplier CyberOptics Corporation (Nasdaq: CYBE) are trading higher on news this morning that net income for the quarter ended March 31 was $1.15 million, or $0.13 per share, what Wall Street was expecting, compared with $1.46 million, or $0.16 per share, in the first quarter of 2006. Shares are up $0.29, or 2.14%, to $13.87.
[ More » ]
LJ International leads pre-market small-cap most actives
The following are the most actively traded companies in pre-market trading among those with market capitalizations under $500 million (at 8:55 ET):
[ More » ]
Small-cap volume leaders
The following are the most actively traded companies at 1:03 ET among those with market capitalizations under $500 million:
[ More » ]
BioDelivery Sciences tops small-cap percentage gainers
These are the biggest percentage gainers at 12:04 Et among companies with market capitalizations under $500 million:
[ More » ]
BioDelivery Sciences soars on positive trial resultsShares of BioDelivery Sciences International Inc. (Nasdaq: BDSI) skyrocketed by 75% on heavy volume this morning after the Morrisville, N.C., drug delivery company announced positive trial results for cancer pain therapy Bema Fentanyl. By 10:21 ET, the stock had shot up $3.48, or 75%, to a new 52-week-high of $8.12 on the news. Prior to today, shares had traded between $1.65 (on June 24, 2006) and $6.35 (on April 11) in the past year. Volume was exceptionally heavy, with more than 4.6 million shares changing hands by 10:23 ET compared with an average three-month daily volume of 137,722 shares. BioDelivery Sciences said that Bema Fentanyl showed a greater reduction in pain when compared to a placebo. Eighty patients participated in the placebo-controlled portion of the study. According to Dr. Andrew Finn, BDSI’s executive vice president of product development, only five patients did not receive “adequate pain relief.” spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer
|
Research
|
